Literature DB >> 26693056

MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.

Xiao-Yu Liu1, Zhi-Jian Liu1, Hong He2, Chen Zhang1, Yun-Long Wang1.   

Abstract

MicroRNAs (miRNAs) play critical roles in carcinogenesis and tumor progression. Recent research has revealed miR-101-3p as an important regulator in several cancers. Nevertheless, its function in salivary gland Adenoid cystic carcinoma (ACC), a relatively rare malignance with poor long-term survival rate arisen in head and neck region, remain unknown. In this study, down-regulated miR-101-3p expression was detected in ACC tissues and ACC cell lines with high potential for metastasis. Ectopic expression of miR-101-3p significantly repressed the invasion, proliferation, colony formation, and formation of nude mice xenografts and induced potent apoptosis in ACC cell lines. The provirus integration site for Moloney murine leukemia virus 1 (Pim-1) oncogene was subsequently confirmed as a direct target gene of miR-101-3p in ACC. Functional restoration assays revealed that miR-101-3p inhibits cell growth and invasion by directly decreasing Pim-1 expression. Protein levels of Survivin, Cyclin D1 and β-catenin were also down-regulated by miR-101-3p. miR-101-3p enhanced the sensitivity of cisplatin in ACC cell lines. Taken together, our results demonstrate that the novel miR-101-3p/Pim-1 axis provides excellent insights into the carcinogenesis and tumor progression of ACC and may be a promising therapeutic target for this type of cancer.

Entities:  

Keywords:  ACC; Pim-1; chemotherapeutic sensitivity; miR-101-3p

Year:  2015        PMID: 26693056      PMCID: PMC4656727     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  44 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.

Authors:  Yuemeng Dai; Cheng-Hui Xie; John P Neis; Chun-Yang Fan; Emre Vural; Paul M Spring
Journal:  Head Neck       Date:  2010-11-29       Impact factor: 3.147

3.  The proto-oncogene Pim-1 is a target of miR-33a.

Authors:  M Thomas; K Lange-Grünweller; U Weirauch; D Gutsch; A Aigner; A Grünweller; R K Hartmann
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

4.  Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.

Authors:  Christopher L Ellington; Michael Goodman; Scott A Kono; William Grist; Trad Wadsworth; Amy Y Chen; Taofeek Owonikoko; Suresh Ramalingam; Dong M Shin; Fadlo R Khuri; Jonathan J Beitler; Nabil F Saba
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

5.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.

Authors:  Hui-Ju Wang; Hong-Jun Ruan; Xu-Jun He; Ying-Yu Ma; Xiao-Ting Jiang; Ying-Jie Xia; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Eur J Cancer       Date:  2010-08       Impact factor: 9.162

Review 6.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

7.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

8.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.

Authors:  Lijuan Sun; Bodu Liu; Zhaoyu Lin; Yandan Yao; Yanyang Chen; Yang Li; Jianing Chen; Dongsheng Yu; Zhangui Tang; Bosheng Wang; Shuguang Zeng; Song Fan; Youyuan Wang; Yilin Li; Erwei Song; Jinsong Li
Journal:  Mol Cancer       Date:  2015-04-29       Impact factor: 27.401

10.  Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.

Authors:  Min Zheng; Ya-ping Jiang; Wei Chen; Kai-de Li; Xin Liu; Shi-yu Gao; Hao Feng; Sha-sha Wang; Jian Jiang; Xiang-rui Ma; Xiao Cen; Ya-jie Tang; Yu Chen; Yun-feng Lin; Ya-ling Tang; Xin-hua Liang
Journal:  Oncotarget       Date:  2015-03-30
View more
  20 in total

1.  Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.

Authors:  Wei Wang; Shuai Han; Wei Gao; Yuan Feng; Kunhang Li; Di Wu
Journal:  Cell Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.046

2.  MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.

Authors:  Yi Wang; Qing-Fei Xing; Xiao-Qiang Liu; Zhan-Jun Guo; Chang-Ying Li; Guang Sun
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

3.  MiR-932 Regulates Pyrethroid Resistance in Culex pipiens pallens (Diptera: Culicidae).

Authors:  Bingqian Liu; Mengmeng Tian; Qin Guo; Lei Ma; Dan Zhou; Bo Shen; Yan Sun; Changliang Zhu
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

Review 4.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

5.  Prognostic Value of microRNA Signature in Patients with Gastric Cancers.

Authors:  Hai-Ting Liu; Ya-Wen Wang; Ai-Yan Xing; Duan-Bo Shi; Hui- Zhang; Xiang-Yu Guo; Jing- Xu; Peng Gao
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

6.  The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.

Authors:  Yusuke Goto; Akira Kurozumi; Nijiro Nohata; Satoko Kojima; Ryosuke Matsushita; Hirofumi Yoshino; Kazuto Yamazaki; Yasuo Ishida; Tomohiko Ichikawa; Yukio Naya; Naohiko Seki
Journal:  Oncotarget       Date:  2016-09-13

7.  MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.

Authors:  Tian Tian; Ma Mingyi; Xia Qiu; Yang Qiu
Journal:  Oncotarget       Date:  2016-11-29

8.  CMIP is oncogenic in human gastric cancer cells.

Authors:  Jianlin Zhang; Jin Huang; Xingyu Wang; Weidong Chen; Qinqing Tang; Maoyong Fang; Yeben Qian
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

9.  MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.

Authors:  Lu Qian; Wanggang Zhang; Bo Lei; Aili He; Lianhong Ye; Xingzhou Li; Xin Dong
Journal:  Oncol Rep       Date:  2016-09-21       Impact factor: 3.906

10.  MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.

Authors:  Huaqi Wang; Li Wang; Guojun Zhang; Chunya Lu; Heying Chu; Rui Yang; Guoqiang Zhao
Journal:  Oncotarget       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.